Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Medtronic recently announced that the Guardian 4 continuous glucose monitor (CGM) and its InPen smart insulin pen will launch this fall in Europe. Both devices have been approved in Europe for people with diabetes. The two will be integrate with one another through real-time data sharing, to help people on multiple daily injections of insulin (MDI) track and calculate insulin doses more easily.
Medtronic’s Guardian 4 is the company’s first CGM that does not require fingerstick calibrations. Guardian 4 has the same shape and seven-day wear as Medtronic’s existing Guardian 3 CGM system, but does not need fingerstick calibrations and users can bolus insulin based on CGM readings alone, without having to perform a confirmatory fingerstick. Both Guardian 3 and 4 sensors have a two-hour warm-up time period, offer customizable predictive low and high glucose alerts, and have an alarm for urgent lows set at 54 mg/dL. In addition to InPen, Guardian 4 integrates with Medtronic’s MiniMed 780G Advanced Hybrid Closed Loop system without the need for fingersticks (and including the new seven-day infusion set), which rolled out in Europe in fall 2020. In the US, both Guardian 4 and Medtronic MiniMed 780G have been submitted to the FDA for approval but are not yet available.
diatribe.org
Medtronic’s Guardian 4 is the company’s first CGM that does not require fingerstick calibrations. Guardian 4 has the same shape and seven-day wear as Medtronic’s existing Guardian 3 CGM system, but does not need fingerstick calibrations and users can bolus insulin based on CGM readings alone, without having to perform a confirmatory fingerstick. Both Guardian 3 and 4 sensors have a two-hour warm-up time period, offer customizable predictive low and high glucose alerts, and have an alarm for urgent lows set at 54 mg/dL. In addition to InPen, Guardian 4 integrates with Medtronic’s MiniMed 780G Advanced Hybrid Closed Loop system without the need for fingersticks (and including the new seven-day infusion set), which rolled out in Europe in fall 2020. In the US, both Guardian 4 and Medtronic MiniMed 780G have been submitted to the FDA for approval but are not yet available.
New Tech Advancements Make Insulin Delivery Easier for People with Diabetes in Europe
Two diabetes devices from Medtronic – a next-gen continuous glucose monitor that removes fingerstick calibrations and a smart insulin delivery pen that keeps track of your insulin doses – will become available in Europe later this year. The two can share data with one another to simplify...